BR9204851A - Antigeno de HIV e processo para sua produçao molécula de DNA recombinante, reagente para diagnóstico e vacina para sindrome da imunodeficiência adquirida - Google Patents

Antigeno de HIV e processo para sua produçao molécula de DNA recombinante, reagente para diagnóstico e vacina para sindrome da imunodeficiência adquirida

Info

Publication number: BR9204851A
Authority: BR; Brazil
Prior art keywords: gag; hiv antigen; env; vaccine; diagnostic reagent
Prior art date: 1992-06-04

Application number

BR9204851A

Other languages

English (en)

Inventor

Atsushi Saito

Hideo Sinagawa

Atsuo Nakata

Original Assignee

Univ Osaka Res Found

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-06-04

Filing date

1992-12-04

Publication date

1994-06-07

1992-12-04 Application filed by Univ Osaka Res Found filed Critical Univ Osaka Res Found

1994-06-07 Publication of BR9204851A publication Critical patent/BR9204851A/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
- C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/974—Aids related test

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Virology (AREA)
Medicinal Chemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Pharmacology & Pharmacy (AREA)
Microbiology (AREA)
Mycology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

BR9204851A 1992-06-04 1992-12-04 Antigeno de HIV e processo para sua produçao molécula de DNA recombinante, reagente para diagnóstico e vacina para sindrome da imunodeficiência adquirida BR9204851A (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP17027092		1992-06-04

Publications (1)

Publication Number	Publication Date
BR9204851A true BR9204851A (pt)	1994-06-07

Family

ID=15901829

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR9204851A BR9204851A (pt)	1992-06-04	1992-12-04	Antigeno de HIV e processo para sua produçao molécula de DNA recombinante, reagente para diagnóstico e vacina para sindrome da imunodeficiência adquirida

Country Status (8)

Country	Link
US (2)	US5576421A (pt)
EP (1)	EP0572737B1 (pt)
KR (1)	KR0143977B1 (pt)
CN (1)	CN1079509A (pt)
AT (1)	ATE199394T1 (pt)
BR (1)	BR9204851A (pt)
CA (1)	CA2084386C (pt)
DE (1)	DE69231705T2 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2178635C (en) *	1993-12-10	2004-05-25	Yu-Wen Hu	Immunofluorescence assay for the detection of antibodies using recombinant antigens in insoluble form
DE4411718A1 (de) *	1994-04-05	1995-10-12	Gsf Forschungszentrum Umwelt	RFB-Retrovirusgenom
EP0907740A1 (en) *	1997-01-02	1999-04-14	Universidade Federal De Minas Gerais	THE PROCESS FOR EXPRESSION AND PRODUCTION OF RECOMBINANT PROTEIN HYBRID PROTEIN (p24/p17) DERIVED FROM HUMAN IMMUNODEFICIENCY VIRUSES (HIV-1)
US6271354B1 (en)	1997-04-03	2001-08-07	Thomas Jefferson University	Chimeric viral proteins
ES2341429T3 (es) *	1999-12-23	2010-06-21	Medical Research Council	Mejoras en las respuestas inmunitarias al vih o relacionadas con las mismas.
EP2280074A3 (en) *	2001-07-05	2011-06-22	Novartis Vaccines and Diagnostics, Inc.	Polynucleotides encoding antigenic HIV type B and/or type C polypeptides, polypeptides and uses thereof
US7611712B2 (en) *	2003-10-23	2009-11-03	Nelson M. Karp	Immunogenic compositions capable of eliciting Th1 immune responses comprising an HIV-1 MA myristate binding site polypeptide
FR2874612A1 (fr) *	2004-08-27	2006-03-03	Commissariat Energie Atomique	Epitotes t cd4+ du vih restreints a hla-dp4 et leurs applications
AU2005335203A1 (en) *	2004-09-08	2007-02-15	The United States Of America As Represented By The Secretary Of Health And Human Services, Nih	Compositions and methods for the detection of HIV-1/HIV-2 infection
KR101138930B1 (ko) *	2007-02-16	2012-04-25	(주) 에빅스젠	Ｈⅰｖｎｃ 단백질을 포함하는 ａⅰｄｓ 예방 및 치료용조성물
CN101475642B (zh) *	2008-11-07	2013-06-05	深圳市菲鹏生物股份有限公司	一种艾滋病毒重组抗原及其融合蛋白
KR102079761B1 (ko) *	2018-05-14	2020-02-20	서울대학교산학협력단	pMyong2 벡터 시스템을 이용하여 HIV-1 p24를 발현하는 재조합 BCG 및 이의 HIV-1 백신으로의 이용

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0227169B1 (en) *	1985-12-17	1993-03-17	Akzo N.V.	Immunochemical reagent
US4925784A (en) *	1986-04-04	1990-05-15	Hoffmann-La Roche Inc.	Expression and purification of an HTLV-III gag/env gene protein
NZ226026A (en) *	1987-09-04	1991-03-26	Wellcome Found	Immunoassay for an antibody using recombinant antigens expressed in two different genera
JPH01179687A (ja) *	1987-12-30	1989-07-17	Chemo Sero Therapeut Res Inst	Ｈｉｖ融合蛋白質
IL90048A0 (en) *	1988-04-25	1989-12-15	Merck & Co Inc	Recombinant gag precursor of hiv,its preparation and its use as aids vaccine
DE68917520T2 (de) *	1988-05-06	1995-01-05	Ferropas Ag	Verfahren und Systeme zur Herstellung von HIV-Antigenen.
CA2003383A1 (en) *	1988-11-23	1990-05-23	Sushil G. Devare	Synthetic dna derived recombinant hiv antigens
JPH04500308A (ja)	1989-05-17	1992-01-23	リサーチ・コーポレーション・テクノロジーズ・インコーポレーテッド	組換え型生成物のレトロウィルス媒介分泌
ES2140380T5 (es) *	1990-03-21	2005-03-16	Geneart Gmbh	Secuencias de adn que codifican polipeptidos gag retroviricos modificados y vacunas que las contienen o agregados de las mismas.

1992
- 1992-12-02 EP EP92311006A patent/EP0572737B1/en not_active Expired - Lifetime
- 1992-12-02 AT AT92311006T patent/ATE199394T1/de not_active IP Right Cessation
- 1992-12-02 DE DE69231705T patent/DE69231705T2/de not_active Expired - Fee Related
- 1992-12-02 CA CA002084386A patent/CA2084386C/en not_active Expired - Fee Related
- 1992-12-04 BR BR9204851A patent/BR9204851A/pt not_active Application Discontinuation
- 1992-12-04 KR KR1019920023362A patent/KR0143977B1/ko not_active Expired - Fee Related
- 1992-12-04 CN CN92115396A patent/CN1079509A/zh active Pending
1995
- 1995-01-18 US US08/375,510 patent/US5576421A/en not_active Expired - Fee Related
- 1995-06-07 US US08/487,657 patent/US5834267A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP0572737A2 (en)	1993-12-08
KR940000117A (ko)	1994-01-03
DE69231705T2 (de)	2001-10-18
ATE199394T1 (de)	2001-03-15
DE69231705D1 (de)	2001-04-05
KR0143977B1 (ko)	1998-07-15
US5576421A (en)	1996-11-19
US5834267A (en)	1998-11-10
EP0572737A3 (en)	1994-11-23
CA2084386A1 (en)	1993-12-05
CN1079509A (zh)	1993-12-15
CA2084386C (en)	2001-02-20
EP0572737B1 (en)	2001-02-28

Publication	Publication Date	Title
AU591054B2 (en)	1989-11-30	Pre-S gene coded peptide hepatitis B immunogens, vaccines and diagnostics
DE3752170T2 (de)	1998-10-08	Synthetisches Antigen zum Nachweis von mit AIDS in Zusammenhang stehenden Krankheiten
BR9204851A (pt)	1994-06-07	Antigeno de HIV e processo para sua produçao molécula de DNA recombinante, reagente para diagnóstico e vacina para sindrome da imunodeficiência adquirida
ES2140380T3 (es)	2000-03-01	Secuencias de adn que codifican polipeptidos gag retroviricos modificados y vacunas que las contienen o agregados de las mismas.
EP0298633A2 (en)	1989-01-11	Synthetic polypeptides
DE3879881D1 (de)	1993-05-06	Rekombinante hiv-2 polypeptide.
JPH01165598A (ja)	1989-06-29	合成ｈｉｖペプチドおよびそれを用いたｈｉｖ抗体の検出法
RU96108781A (ru)	1999-04-20	Пептиды, создающие нейтрализующие антитела к генетически дифергентным штаммам вич-1
ES2156902T3 (es)	2001-08-01	Peptidos que inducen la produccion de anticuerpos neutralizantes contra cepas de vih-1 geneticamente divergentes.
US6080846A (en)	2000-06-27	Composition containing a B epitope of the envelope glycoprotein of a retrovirus and a T epitope of another distinct protein of this retrovirus
KR920002629A (ko)	1992-02-28	B형 간염 코어 항원의 아미노산 잔기 서열
WO1997039029A3 (en)	2001-06-28	An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof
GB2336844A (en)	1999-11-03	Anti-hiv peptides and proteins
HU906421D0 (en)	1991-04-29	Process for testing analogous peptides of hiv
KR920703102A (ko)	1992-12-17	인간 면역결핍 바이러스(human immunodeficiency virus)에 대한 항체와 선택적으로 반응하는 폴리펩타이드 및 그를 함유하는 백신(vaccines)
Madaule et al.	1991	A peptide library expressed in yeast reveals new major epitopes from human immunodeficiency virus type 1
Tallet et al.	2000	Expression, purification and biological properties of the carboxyl half part of the HTLV-I surface envelope glycoprotein
DK362088A (da)	1988-06-30	Fusionsproteiner og fusionsproteinpartikler
GR1000021B (el)	1990-01-31	Αντιπροσωπευτικο προιον ανοσιογενους ανασυνδυαζομενης ζυμης & μεθοδος καθαρισμου της.
JPH05271282A (ja)	1993-10-19	環状主要ｈｉｖ中和決定基とｔ細胞刺激エピトープとを含む合成ペプチド

Legal Events

Date	Code	Title	Description
1997-02-18	FA1	Application withdrawn (art. 18(2))
2018-03-27	B15K	Others concerning applications: alteration of classification	Ipc: C07K 14/005 (2006.01), A61K 39/00 (2006.0